Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001564590-19-002367
Filing Date
2019-02-08
Accepted
2019-02-08 11:51:55
Documents
6
Effectiveness Date
2019-02-08

Document Format Files

Seq Description Document Type Size
1 S-8 mygn-s8.htm S-8 95220
2 EX-5.1 mygn-ex51_6.htm EX-5.1 17368
3 EX-23.1 mygn-ex231_7.htm EX-23.1 2748
4 EX-23.3 mygn-ex233_22.htm EX-23.3 2586
5 GRAPHIC gj2twxjjcrui000002.jpg GRAPHIC 8006
6 GRAPHIC gj2twxjjcrui000001.jpg GRAPHIC 10797
  Complete submission text file 0001564590-19-002367.txt   145088
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

IRS No.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
Type: S-8 | Act: 33 | File No.: 333-229574 | Film No.: 19578689
SIC: 2835 In Vitro & In Vivo Diagnostic Substances